• European Medical Solutions posted Q2 2026 revenue of EUR 12.1 million, down 4% year over year.
• H1 2026 revenue totaled EUR 22.1 million, down 6%; radiology revenue fell 9% to EUR 17.1 million.
• Osteodensitometry revenue rose 6% to EUR 5 million; Q2 segment growth accelerated to 32%.
• OEM white-label sales mix dropped to 38% of radiology activity from 57%; own-brand radiology sales rose 36% to 62% of the mix.
• Group maintained its target for full-year 2026 revenue growth, citing typical second-half seasonality despite geopolitical-driven delays.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. European Medical Solutions published the original content used to generate this news brief on July 20, 2026, and is solely responsible for the information contained therein.